We are live on ! Find out more
HCM

Highline Capital Management Portfolio holdings

AUM $53.5M
1-Year Est. Return 21.72%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
-21.72%
3 Year Est. Return
+197.64%
5 Year Est. Return
+251.63%
10 Year Est. Return
AUM
$2.99B
AUM Growth
+$54.5M
Cap. Flow
-$16.8M
Cap. Flow %
-0.56%
Top 10 Hldgs %
47.74%
Holding
54
New
19
Increased
6
Reduced
14
Closed
13

Top Sells

Rank Stock Value
1
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$109M
2
BIIB icon
Biogen
BIIB
+$99M
3
PM icon
Philip Morris
PM
+$97.4M
4
AVGO icon
Broadcom
AVGO
+$93.6M
5
MT icon
ArcelorMittal
MT
+$92M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 21.21%
2 Healthcare 14.93%
3 Technology 13.47%
4 Communication Services 13.28%
5 Real Estate 10.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DAY
26
DELISTED
Dayforce
DAY
$50.8M 1.7%
+1,529,160
New +$53.8M
TFCFA
27
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$47.8M 1.6%
962,900
+511,800
+113% +$20.2M
ATVI
28
DELISTED
Activision Blizzard
ATVI
$45.8M 1.53%
+600,000
New +$42.5M
CPLG
29
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
$44.3M 1.48%
+1,709,999
New +$45M
RARE icon
30
Ultragenyx Pharmaceutical
RARE
$2.46B
$31.5M 1.06%
+410,000
New +$26.5M
FPAC.U
31
DELISTED
Far Point Acquisition Corporation Units, each consisting of one share of Class A common stock, $0.00
FPAC.U
$27.9M 0.93%
+2,735,010
New +$27.8M
RGNX icon
32
Regenxbio
RGNX
$616M
$25.1M 0.84%
+350,000
New +$16.7M
NVCR icon
33
NovoCure
NVCR
$1.76B
$24.3M 0.81%
774,910
-255,000
-25% -$7.09M
HGV icon
34
Hilton Grand Vacations
HGV
$4.04B
$17.8M 0.6%
513,560
-1,408,210
-73% -$57M
ATVI
35
CALL
DELISTED
Activision Blizzard
ATVI
$17.2M 0.58%
+225,000
New +$15.9M
URGN icon
36
UroGen Pharma
URGN
$1.97B
$16.5M 0.55%
331,900
-44,923
-12% -$2.61M
VYGR icon
37
Voyager Therapeutics
VYGR
$181M
$16.4M 0.55%
+840,670
New +$16.6M
MT icon
38
ArcelorMittal
MT
$49.5B
$9.16M 0.31%
318,297
-2,772,003
-90% -$92M
ATRA icon
39
Atara Biotherapeutics
ATRA
$72.6M
$8.36M 0.28%
+9,096
New +$9.77M
EAGLU
40
DELISTED
Platinum Eagle Acquisition Corp. Unit
EAGLU
$5.09M 0.17%
500,000
SLDB icon
41
Solid Biosciences
SLDB
$792M
$1.87M 0.06%
+3,494
New +$1.08M
AVGO icon
42
Broadcom
AVGO
$1.76T
-3,970,000
Closed -$93.6M
BIIB icon
43
Biogen
BIIB
$30.9B
-361,450
Closed -$99M
BTI icon
44
British American Tobacco
BTI
$136B
-1,422,500
Closed -$82.1M
BYD icon
45
CALL
Boyd Gaming
BYD
$6.75B
-486,900
Closed -$15.5M
EVR icon
46
Evercore
EVR
$11.8B
-376,500
Closed -$32.8M
FDX icon
47
FedEx
FDX
$73B
-366,200
Closed -$87.9M
GPK icon
48
Graphic Packaging
GPK
$3.35B
-400,000
Closed -$6.14M
NUE icon
49
Nucor
NUE
$58.3B
-677,000
Closed -$41.4M
PM icon
50
Philip Morris
PM
$309B
-980,000
Closed -$97.4M

Similar funds

Highline Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Highline Capital Management held 54 positions worth $2.99B, up 1.9% from $2.93B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Highline Capital Management's Q2 2018 filing shows 19 new, 6 increased, 14 reduced and 13 closed positions. Its largest new stake was Pioneer Natural Resource Co.: 617,840 shares worth $117M. The largest sale was Zayo Group Holdings, Inc., an estimated $109M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.

  • Highline Capital Management's largest Q2 2018 buy was Pioneer Natural Resource Co.: 617,840 shares worth $117M.
  • Highline Capital Management added most to Equinix in Q2 2018, an estimated $95M increase.
  • Highline Capital Management's biggest Q2 2018 reduction was ArcelorMittal, cutting an estimated $92M.
  • Highline Capital Management fully exited Zayo Group Holdings, Inc. in Q2 2018, selling an estimated $109M.
  • Highline Capital Management's ten largest holdings make up 48% of its $2.99B portfolio in Q2 2018.
  • Highline Capital Management opened 19 new positions and closed 13 in Q2 2018.
  • Highline Capital Management's portfolio value rose 1.9% quarter-over-quarter to $2.99B.

Based on Highline Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.